CUA Webinars

Tuesday June 16, 2020

5:00pm PDT | 8:00pm EDT | 9:00pm ADT

MANAGEMENT OF NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (nmCRPC)

Featuring: Ricardo Rendon

>Describe the rationale for treating men with prostate cancer earlier in the (non-metastatic) CRPC state
>Identify patients who are appropriate for treatment of their nmCRPC
>Discuss treatment options in the management of nmCRPC
>Describe appropriate follow-up of patients with nmCRPC
>Devise strategies for implementing nmCRPC management practices

[Accredited for Section 1]

SIGN UP HERE >>

 


PAST WEBINARS:

 

CUA HIGHLIGHTS PRESENTED LIVE FROM GU ASCO2020

Faculty: Fred Saad, Nicholas James, Peter Black, Scott North, Anil Kapoor, Christian Kollmannsberger


Managing Advanced Urothelial Carcinoma in 2020: Canadian Consensus Updates

Dr. Aly-Khan Lalani


Practical Considerations for Health Professional-Led Advocacy

Robert Bick | Mona Sabharwal | Naveen Basappa


Management of Advanced Urothelial Carcinoma: Emerging Therapies and Biomarkers

Dr. Scott North

CLICK HERE TO PLAY AUDIO PODCAST


Cancer Advocacy in Canada - A 2019 Perspective

Robert Bick | Paul Wheatley-Price | Barry Stein

 


New Treatment Options for Adults and Children with Overactive Bladder

Dr. Dean Elterman


Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada Consensus (KCRNC) Update 2019

Dr. Sebastien Hotte & Dr. Anil Kapoor


Transvaginal mesh in the management of SUI: Addressing your concerns

Dr. Kevin Carlson & Dr. Blayne Welk

 


New Treatment Options for Adults and Children with Overactive Bladder

Dr. Sender Herschorn


Monitoring Prostate Cancer to Guide Treatment Decision-Making 

Dr. Ricardo Rendon
Dr. Fred Saad

What's new in RCC and implications for patients in Canada

 

Debate: In the second line setting, how do you make clinical decisions in tha absence of evidence?

Dr. Aly-Khan Lalani | Dr. Anil Kapoor vs. Dr. Sebastien Hotte

 
 <CLAIM SECTION 3 CREDITS BY CLICKING HERE>

TSC related Angiomyolipoma - Management Strategies and Case Studies

Dr. Anil Kapoor

 

 <CLAIM SECTION 3 CREDITS BY CLICKING HERE>

New Immuno-oncology Combinations for Untreated Metastatic Kidney Cancer: An Emerging New Standard of Care?

Dr. Scott North & Dr. Anil Kapoor

 

 <CLAIM SECTION 3 CREDITS BY CLICKING HERE>


New Immuno-oncology Combinations for Untreated Metastatic Kidney Cancer: An Emerging New Standard of Care?

Dr. Scott North & Dr. Anil Kapoor



Testosterone Suppression in the Treatment of Recurrent or Metastatic Prostate Cancer - A Canadian Consensus Statement 

Dr. Laurie Klotz